🇺🇸 corticotherapy in United States
39 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 39
Most-reported reactions
- Dyspnoea — 5 reports (12.82%)
- Multi-Organ Failure — 5 reports (12.82%)
- Renal Failure — 5 reports (12.82%)
- Toxic Skin Eruption — 5 reports (12.82%)
- Hypoxia — 4 reports (10.26%)
- Alanine Aminotransferase Increased — 3 reports (7.69%)
- Cardiac Failure — 3 reports (7.69%)
- Condition Aggravated — 3 reports (7.69%)
- Cyanosis — 3 reports (7.69%)
- Erythema — 3 reports (7.69%)
Other Other approved in United States
Frequently asked questions
Is corticotherapy approved in United States?
corticotherapy does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for corticotherapy in United States?
Assistance Publique - Hôpitaux de Paris is the originator. The local marketing authorisation holder may differ — check the official source linked above.